Impilo

Immedica is a niche specialty pharmaceutical company focused on the commercialization and distribution of specialty pharmaceuticals, particularly in the areas of metabolic diseases, oncology, and ophthalmology. The company specializes in orphan medicines targeted at rare diseases, providing essential treatments that cater to specific medical needs. Through its efforts, Immedica aims to enhance access to niche drugs for clients, ensuring that patients with rare conditions receive the therapies they require.

Scantox is a contract research organization located in Lille Skensved, Denmark, specializing in pharmacology and regulatory toxicology services. The company provides preclinical research services tailored for the pharmaceutical and medical device industries, assisting clients in advancing their drug or device development with reliable data that meets technical and scientific standards. Scantox offers a range of services, including safety pharmacology, exploratory testing, and endotoxin testing, ensuring comprehensive support throughout the product development process.

Cavidi AB, founded in 1984 as a spin-off from Uppsala University, is a Swedish biotech company specializing in viral load solutions for HIV monitoring. The company offers ZIVA Viral Load and ExaVIR Load systems for efficient management of anti-HIV drugs (ARV therapy), enabling people living with HIV to maintain a normal lifespan. These diagnostics also help reduce treatment costs and the spread of HIV. Cavidi provides research products and services, including reverse transcriptase activity kits and viral titer measurement services, to hospitals, patient clinics, private laboratories, pharmaceutical industries, and research institutions globally. The company's head office is in Uppsala, Sweden, with additional sales offices in South Africa, India, and the United States.